Related Experiment Video
Updated: Jun 4, 2026
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
NDRG2 expression regulates CD24 and metastatic potential of breast cancer cells
Abstract:
Breast cancer is the most common malignancy in women in the world. High incidence and poor clinical outcomes underly the need for a better understanding of its tumor biology and how to effectively inhibit tumor progression. In the present study the question of whether NDRG2 might be a useful target for breast cancer therapy was addressed. With the increase or decrease of NDRG2 levels in MCF-7 and Bcap-37 cells by adenovirus-NDRG2 infection or NDRG2 siRNA transfection, CD24 expression was significantly decreased or increased, respectively. Furthermore, NDRG2 overexpression suppressed breast cancer cell adhesion and invasion, whereas knockdown of NDRG2 promoted these events. In conclusion, the data from the current study indicated that NDRG2, the product of a tumor suppressor gene, can regulate CD24 expression to decrease the metastatic potential of breast cancer cells.
Insights
NDRG2, a tumor suppressor gene product, regulates CD24 expression. This finding suggests NDRG2 may be a therapeutic target to reduce breast cancer metastasis.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Breast cancer is a leading global malignancy in women.
- Understanding tumor biology is crucial for effective treatment and improved outcomes.
- Identifying novel therapeutic targets is essential for inhibiting breast cancer progression.
Purpose of the Study:
- To investigate the role of NDRG2 (N-myc downstream regulated gene 2) in breast cancer.
- To determine if NDRG2 can be a viable target for breast cancer therapy.
Main Methods:
- Manipulating NDRG2 levels in breast cancer cell lines (MCF-7 and Bcap-37) using adenovirus-NDRG2 infection and NDRG2 siRNA transfection.
- Assessing the impact of altered NDRG2 levels on CD24 expression.
- Evaluating the effects of NDRG2 modulation on breast cancer cell adhesion and invasion.
Main Results:
- Increased NDRG2 levels led to decreased CD24 expression.
- Decreased NDRG2 levels resulted in increased CD24 expression.
- NDRG2 overexpression suppressed breast cancer cell adhesion and invasion.
- NDRG2 knockdown promoted breast cancer cell adhesion and invasion.
Conclusions:
- NDRG2, a tumor suppressor gene product, plays a significant role in regulating breast cancer cell behavior.
- NDRG2 influences CD24 expression, impacting the metastatic potential of breast cancer cells.
- NDRG2 represents a potential therapeutic target for reducing breast cancer metastasis.
Related Concept Videos
02:38Mitogens and the Cell Cycle
01:23Negative Regulator Molecules